Marco Costa MD PhD MBA Named New President of UH Harrington Heart & Vascular Institute

MARCO COSTA, MD, PHD, MBA
President, UH Harrington Heart & Vascular Institute
Angela & James Hambrick Master Clinician of Cardiovascular Innovation
Professor of Medicine, Case Western Reserve University School of Medicine

Harrington Heart & Vascular Institute Innovations - Summer 2016 - View Full PDF

University Hospitals Harrington Heart & Vascular Institute leadership has selected Marco Costa, MD, PhD, MBA, as its new President.

Dr. Costa succeeds Daniel I. Simon, MD, who served as the institute’s first President, and is now the President of UH Case Medical Center. Dr. Simon was pivotal in shaping and strengthening the institute into one of the premier institutes in the country, with more than 1,000 employees delivering the highest-quality of care in 18 hospitals across Northeast Ohio.

The appointment follows an extensive search for a highly qualified individual to lead the institute.

“Dr. Costa’s scientific accomplishments, combined with a talent for developing creative solutions to some of medicine’s biggest challenges, are valuable assets as he begins his new leadership role at UH Harrington Heart & Vascular Institute,” says Jeffrey Peters, MD, Chief Operating Officer, University Hospitals. “We look forward to the future of the institute with Dr. Costa and his team as we continue to deliver the highest-quality care and extraordinary experience to our patients.”

Since 2007, Dr. Costa has worked alongside Dr. Simon leading the Interventional Cardiovascular Center to become a regional market leader and a national center of excellence. He will continue his prominent medical practice treating patients with the most complex and advanced heart and vascular diseases through catheter-based, minimally invasive approaches.

Dr. Costa is among a select group of physician investigators whose work has helped change medical practice worldwide. He was one of the pioneers of drug-eluting stents, a revolutionary technology at the time and now standard treatment for coronary artery disease. His reputation as a world-class physician-investigator is supported by an impressive number of original manuscripts published in top scientific journals and invited lectures around the world. More recently, Dr. Costa helped develop intravascular optical coherence tomography, an imaging technology capable of acquiring micron-scale images of human blood vessels. He is currently leading global studies of new therapies for patients with valve disease and heart failure.

He is also actively engaged in promoting global health, having performed the first minimally invasive heart and vascular procedures in Uganda.

Dr. Costa received his executive MBA degree from the MIT Sloan School of Management, and has successfully applied modern principles of strategy and management during his tenure at the helm of UH’s Executive Office of In his new role, Dr. Costa will oversee UH Harrington Heart & Vascular Institute’s clinical, educational, research and administrative programs. He will continue to serve as Chief Innovation Officer at University Hospitals.